Throughout the whole Alzheimer’s continuum (Fig. 4D), we observed that plasma GFAP and p-tau181 continued to increase, while plasma NfL levels plateaued during the MCI+ and AD dementia phases. Here, NEFL is linked to Alzheimer disease.